230 related articles for article (PubMed ID: 34194431)
1. c-Rel Is Required for IL-33-Dependent Activation of ILC2s.
Zaini A; Fulford TS; Grumont RJ; Runting J; Rodrigues G; Ng J; Gerondakis S; Zaph C; Scheer S
Front Immunol; 2021; 12():667922. PubMed ID: 34194431
[TBL] [Abstract][Full Text] [Related]
2. The NF-κB Transcription Factor c-Rel Modulates Group 2 Innate Lymphoid Cell Effector Functions and Drives Allergic Airway Inflammation.
Mindt BC; Krisna SS; Duerr CU; Mancini M; Richer L; Vidal SM; Gerondakis S; Langlais D; Fritz JH
Front Immunol; 2021; 12():664218. PubMed ID: 34867937
[TBL] [Abstract][Full Text] [Related]
3. Interplay Between the IL-33/ST2 Axis and Bone Marrow ILC2s in Protease Allergen-Induced IL-5-Dependent Eosinophilia.
Boberg E; Johansson K; Malmhäll C; Calvén J; Weidner J; Rådinger M
Front Immunol; 2020; 11():1058. PubMed ID: 32582171
[No Abstract] [Full Text] [Related]
4. SLAM-family receptors promote resolution of ILC2-mediated inflammation.
Wang Y; Quan Y; He J; Chen S; Dong Z
Nat Commun; 2024 Jun; 15(1):5056. PubMed ID: 38871792
[TBL] [Abstract][Full Text] [Related]
5. ICAM-1 controls development and function of ILC2.
Lei AH; Xiao Q; Liu GY; Shi K; Yang Q; Li X; Liu YF; Wang HK; Cai WP; Guan YJ; Gabrilovich DI; Zhou J
J Exp Med; 2018 Aug; 215(8):2157-2174. PubMed ID: 30049704
[TBL] [Abstract][Full Text] [Related]
6. Interferon-γ constrains cytokine production of group 2 innate lymphoid cells.
Kudo F; Ikutani M; Seki Y; Otsubo T; Kawamura YI; Dohi T; Oshima K; Hattori M; Nakae S; Takatsu K; Takaki S
Immunology; 2016 Jan; 147(1):21-9. PubMed ID: 26425820
[TBL] [Abstract][Full Text] [Related]
7. Spred1, a Suppressor of the Ras-ERK Pathway, Negatively Regulates Expansion and Function of Group 2 Innate Lymphoid Cells.
Suzuki M; Morita R; Hirata Y; Shichita T; Yoshimura A
J Immunol; 2015 Aug; 195(3):1273-81. PubMed ID: 26116510
[TBL] [Abstract][Full Text] [Related]
8. IL-17-producing ST2
Cai T; Qiu J; Ji Y; Li W; Ding Z; Suo C; Chang J; Wang J; He R; Qian Y; Guo X; Zhou L; Sheng H; Shen L; Qiu J
J Allergy Clin Immunol; 2019 Jan; 143(1):229-244.e9. PubMed ID: 29625134
[TBL] [Abstract][Full Text] [Related]
9. HTR2A agonists play a therapeutic role by restricting ILC2 activation in papain-induced lung inflammation.
Wang Z; Yan C; Du Q; Huang Y; Li X; Zeng D; Mao R; Gurram RK; Cheng S; Gu W; Zhu L; Fan W; Ma L; Ling Z; Qiu J; Li D; Liu E; Zhang Y; Fang Y; Zhu J; Sun B
Cell Mol Immunol; 2023 Apr; 20(4):404-418. PubMed ID: 36823235
[TBL] [Abstract][Full Text] [Related]
10. Targeting androgen signaling in ILC2s protects from IL-33-driven lung inflammation, independently of KLRG1.
Blanquart E; Mandonnet A; Mars M; Cenac C; Anesi N; Mercier P; Audouard C; Roga S; Serrano de Almeida G; Bevan CL; Girard JP; Pelletier L; Laffont S; Guéry JC
J Allergy Clin Immunol; 2022 Jan; 149(1):237-251.e12. PubMed ID: 33964300
[TBL] [Abstract][Full Text] [Related]
11. The Prostaglandin D
Oyesola OO; Duque C; Huang LC; Larson EM; Früh SP; Webb LM; Peng SA; Tait Wojno ED
J Immunol; 2020 Feb; 204(4):1001-1011. PubMed ID: 31900341
[TBL] [Abstract][Full Text] [Related]
12. The neuropeptide neuromedin U stimulates innate lymphoid cells and type 2 inflammation.
Klose CSN; Mahlakõiv T; Moeller JB; Rankin LC; Flamar AL; Kabata H; Monticelli LA; Moriyama S; Putzel GG; Rakhilin N; Shen X; Kostenis E; König GM; Senda T; Carpenter D; Farber DL; Artis D
Nature; 2017 Sep; 549(7671):282-286. PubMed ID: 28869965
[TBL] [Abstract][Full Text] [Related]
13. COX Inhibition Increases
Zhou W; Zhang J; Toki S; Goleniewska K; Norlander AE; Newcomb DC; Wu P; Boyd KL; Kita H; Peebles RS
J Immunol; 2020 Aug; 205(4):1157-1166. PubMed ID: 32690653
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporin A indirectly attenuates activation of group 2 innate lymphoid cells in papain-induced lung inflammation.
Kudo F; Ikutani M; Iseki M; Takaki S
Cell Immunol; 2018 Jan; 323():33-40. PubMed ID: 29108648
[TBL] [Abstract][Full Text] [Related]
15. Eosinophils promote effector functions of lung group 2 innate lymphoid cells in allergic airway inflammation in mice.
LeSuer WE; Kienzl M; Ochkur SI; Schicho R; Doyle AD; Wright BL; Rank MA; Krupnick AS; Kita H; Jacobsen EA
J Allergy Clin Immunol; 2023 Aug; 152(2):469-485.e10. PubMed ID: 37028525
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-155 is a critical regulator of type 2 innate lymphoid cells and IL-33 signaling in experimental models of allergic airway inflammation.
Johansson K; Malmhäll C; Ramos-Ramírez P; Rådinger M
J Allergy Clin Immunol; 2017 Mar; 139(3):1007-1016.e9. PubMed ID: 27492144
[TBL] [Abstract][Full Text] [Related]
17. Leukotriene C4 Potentiates IL-33-Induced Group 2 Innate Lymphoid Cell Activation and Lung Inflammation.
Lund SJ; Portillo A; Cavagnero K; Baum RE; Naji LH; Badrani JH; Mehta A; Croft M; Broide DH; Doherty TA
J Immunol; 2017 Aug; 199(3):1096-1104. PubMed ID: 28667163
[TBL] [Abstract][Full Text] [Related]
18. Th2 cell-derived IL-4/IL-13 promote ILC2 accumulation in the lung by ILC2-intrinsic STAT6 signaling in mice.
Symowski C; Voehringer D
Eur J Immunol; 2019 Sep; 49(9):1421-1432. PubMed ID: 31144294
[TBL] [Abstract][Full Text] [Related]
19. Female and male mouse lung group 2 innate lymphoid cells differ in gene expression profiles and cytokine production.
Mathä L; Shim H; Steer CA; Yin YH; Martinez-Gonzalez I; Takei F
PLoS One; 2019; 14(3):e0214286. PubMed ID: 30913260
[TBL] [Abstract][Full Text] [Related]
20. Leukotrienes provide an NFAT-dependent signal that synergizes with IL-33 to activate ILC2s.
von Moltke J; O'Leary CE; Barrett NA; Kanaoka Y; Austen KF; Locksley RM
J Exp Med; 2017 Jan; 214(1):27-37. PubMed ID: 28011865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
